JOHNSON JOHN reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/1/2024ACC: 0001867096-24-000039
Director
Since Oct 2021
+89.57K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
89.57K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+89.57K
Price / share
—
Trade value
—
% of position
11.9%
3/15/2024
751.41K→840.98K
Total
Net shares
+89.57K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2024 | J · J | +89.57K | — | — | 11.9% | 751.41K | 840.98K |
| Total | +89.57K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported